Amedisys, Inc. (AMED) Misses Q2 EPS by 1c; Cuts FY11 Outlook

August 2, 2011 7:11 AM EDT Send to a Friend
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.67, $0.01 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $373.7 million versus the consensus estimate of $383.21 million.

Amedisys, Inc. sees FY2011 EPS of $2.20-$2.40, versus the consensus of $2.94. Prior guidance was for $3.00-$3.30. Amedisys, Inc. sees FY2011 revenue of $1.475-$1.5 billion, versus the consensus of $1.58 billion.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance, Trading Halts

Add Your Comment